1. Male rats were injected daily for 5 days with 0.15M-NaCl, corticotropin, cortisol or L-thyroxine and the rates of glycerolipid synthesis were measured in the livers after intraportal injection of [14C] and '4C in diacylglycerol. It did not significantly alter the accumulation of these isotopes in phosphatidate nor the activity of the soluble phosphatidate phosphohydrolase in the total liver. However, this activity increased by 1.5-fold when expressed relative to the soluble protein of the liver. The increased triacylglycerol synthesis appears to be related to a general increase in the turnover of fatty acids in the liver. 5. Treatment with cortisol and corticotropin increased the relative rate of triacylglycerol synthesis from [3H]glycerol, decreased the accumulation of 3H in phosphatidate and increased the flux of both isotopes from phosphatidate to diacylglycerol. This appeared to be caused by the increased activity of the soluble phosphatidate phosphohydrolase that was observed in the livers of the cortisol-treated rats. 6. It is proposed that cortisol could be directly or indirectly involved in increasing the activity of hepatic phosphatidate phosphohydrolase in starvation, diabetes, laparotomy, subtotal hepatectomy, liver damage, ethanol feeding and in obesity. This enzyme adaptation could contribute to the potential of the liver to increase its synthesis and accumulation of triacylglycerols or to secrete very-low-density lipoproteins.
1. Male rats were injected daily for 5 days with 0.15M-NaCl, corticotropin, cortisol or L-thyroxine and the rates of glycerolipid synthesis were measured in the livers after intraportal injection of [14C]palmitate and [3H]glycerol. 2. Injection of all three hormones decreased the rates of body-weight gain. 3. Cortisol treatment increased the weight of the liver relative to body weight. 4 . Thyroxine treatment increased the relative rate of triacylglycerol synthesis from [3H]glycerol and decreased the relative accumulation of 3H and '4C in diacylglycerol. It did not significantly alter the accumulation of these isotopes in phosphatidate nor the activity of the soluble phosphatidate phosphohydrolase in the total liver. However, this activity increased by 1.5-fold when expressed relative to the soluble protein of the liver. The increased triacylglycerol synthesis appears to be related to a general increase in the turnover of fatty acids in the liver. 5. Treatment with cortisol and corticotropin increased the relative rate of triacylglycerol synthesis from [3H]glycerol, decreased the accumulation of 3H in phosphatidate and increased the flux of both isotopes from phosphatidate to diacylglycerol. This appeared to be caused by the increased activity of the soluble phosphatidate phosphohydrolase that was observed in the livers of the cortisol-treated rats. 6. It is proposed that cortisol could be directly or indirectly involved in increasing the activity of hepatic phosphatidate phosphohydrolase in starvation, diabetes, laparotomy, subtotal hepatectomy, liver damage, ethanol feeding and in obesity. This enzyme adaptation could contribute to the potential of the liver to increase its synthesis and accumulation of triacylglycerols or to secrete very-low-density lipoproteins.
Recent experimental evidence indicates that phosphatidate phosphohydrolase is an important regulatory enzyme in the synthesis of triacylglycerols in the liver Brindley, 1978a,b) . Although the responses of this enzyme to a number of physiological and pharmacological changes are documented, there is little information about the alterations of phosphatidate phosphohydrolase activity during hormonal modification. It appears that this activity in the liver is not maintained by insulin, since it is increased in starvation and diabetes and in the stress caused by laparotomy and subtotal hepatectomy (Brindley, 1978a,b) .
In the present experiments rats were injected with thyroxine, corticotropin (ACTH) and cortisol, since these hormones are thought to modify glycerolipid metabolism in the liver. This was tested by studying the fate of intraportally injected [3H] 
Materials and Methods

Materials
The source of most of these has been described (Brindley et al., 1976; . Cortisol (as the 21-acetate), corticotropin and Lthyroxine (sodium salt) were purchased from Sigma (London) Chemical Co., Kingston upon Thames, Surrey, U.K.
Treatment of rats
Male Wistar rats [176% (S.D. ± 16), n = 68] were allowed free access to a 41B diet and water. They were divided into four groups and were given daily intramuscular injections into the thigh for 5 days. The injection consisted of (1) 1 ml of 0.15 M-NaCl/kg body wt. (control rats), or the equivalent volume of 0.15M-NaCl containing a dose of (2) 100mg of cortisol as a suspension/kg body wt., (3) 580,ug (50 i.u.) of corticotropin/kg body wt. or (4) 500,ug of L-thyroxine/kg body wt.
Measurement of the rate of hepatic glycerolipid synthesis in vivo At 3h after the injection with 0.15M-NaCl or hormones on day 5, the rate of glycerolipid synthesis in the liver was measured 1 min after the intraportal injection (0.25ml) of 212,uM-[1-'4C]palmitate (sp. radioactivity 58piCi/,umol) and 188 uM-[1,3-3H]-glycerol (sp. radioactivity 1638,pCi/pmol) (Brindley et al., 1976; Glenny et al., 1978) .
Measurement of the soluble phosphatidate phosphohydrolase activity Rats were killed by cervical dislocation 3h after the fifth injection with hormones. The particle-free supernatant was prepared, dialysed and the activity of the enzyme was determined by measuring the release of Pi from phosphatidate (Whiting et al., 1977) . This assay gives results that are equivalent to those obtained when the formation of diacylglycerol is measured (Sturton & Brindlcy, 1978) .
Experimental and Results
Injection of cortisol, corticotropin or thyroxine significantly decreased the weight gain of the rats over the 5-day period by 14, 3 and 5 % respectively ( Roncari & Murthy (1975) and they did not obtain a significant effect on body weight. However, Coates et al. (1978) did report a small decrease in weight gain with a larger dose (about 2mg/kg body wt.) of thyroxine. The injection of 225 mg of cortisol daily for 5 days to rats has been reported to produce a 9 % decrease in body weight (Weber & Singhal, 1964) . Walker (1975) attributed the decreased body-weight gain in rats receiving dexamethasone, a synthetic glucocorticoid, in conjunction with a 20 % (by weight) rapeseed-oil diet to an increased mobilization of fat-depots.
The liver weights of the rats treated with hormones were not significantly different from those of the controls, although the livers of the cortisol-treated rats were heavier than those of the thyroxine-treated rats (Table 1 ). The livers of the rats given cortisol were heavier than those of the other groups if the results are expressed relative to the body weight. Other authors have reported that injecting cortisol increases this ratio (Weber & Singhal, 1964; Bates & Garrison, 1974) , which is probably partly caused by an increase in the content of liver glycogen (Weber & Singhal, 1964) and triacylglycerol (Ozegovic et al., 1975) . The liver/body weight ratio was also increased by 20-30% after daily treatment for 5 days with corticotropin (80 i.u./160-200g rat), but this dose is 8-10-fold greater than was used in the present work.
Effect ofinjecting cortisol, corticotropin and thyroxine on the hepatic synthesis ofglycerolipids in vivo
The experiments were carried out to provide evidence that injecting the hormones caused changes in the hepatic glycerolipid metabolism of the rats described in Table 1 . This approach has already been used to study the effects of dietary modification and the effects of drugs (Brindley et al., 1976; Savolainen, 1977; Glenny et al., 1978) . (Tables 2 and 3) . Klausner & Heimberg (1967) found that cortisol did not alter the uptake of fatty acids in a perfused-liver system, Table 1 . Effects of injecting cortisol, corticotropin and L-thyroxine on the liver and body weights of rats Rats were injected daily for 5 days with saline or hormones as described in the Materials and Methods section. The results are expressed as means ± S.D. and the number of rats is shown in parentheses. The significance of the difference between groups is indicated by: *P < 0.05; tP < 0.005; ttP < 0.001. (Table 3 ) and the recovery of the total "4C-labelled glycerolipids from the livers of the thyroxine-treated rats was significantly lower than that in the controls (Table 2) .
Effect of injecting rats with cortisol and L-thyroxine on the soluble activity of phosphatidate phosphohydrolase
The results in Tables 2 and 3 show that injections of cortisol and thyroxine alter the rates of hepatic triacylglycerol synthesis in vivo. These changes may be partly caused by alterations in the activities of the enzymes responsible for this synthesis. The activity of phosphatidate phosphohydrolase was investigated, since it is this activity that normally changes the most rapidly and dramatically when the synthesis of triacylglycerols in the liver is altered (Brindley, 1978a,b) .
The specific activity of phosphatidate phosphohydrolase was increased by 2.4-fold (relative to protein) and by 2.8-fold based on the activity per liver in the cortisol-treated rats (Table 4) . Thyroxine treatment produced a 1.5-fold increase in specific activity of the phosphohydrolase (relative to protein), but it did not significantly alter the activity expressed per liver. The latter way of expressing the results is more meaningful, since thyroxine treatment may alter the concentration of soluble protein in the liver, although this change did not reach the level of significance (Table 1 ). In addition, the solubleprotein concentration is affected by the extent to which the livers were perfused, and this adds a further variable.
Discussion
The doses of hormones used in the present experiments are within the ranges employed by other authors who have studied the metabolic effects of cortisol (Weber & Singhal, 1964; Litwack & Singer, 1972; Walter & Anabitarte, 1973; Bates & Garrison, 1974) , corticotropin (Szabo et al., 1973) and thyroxine (Tepperman & Tepperman, 1964; Gibson Table 4 . Effect of injecting rats with cortisol and L-thyroxine on the soluble activity ofphosphatidate phosphohydrolase in the liver Rats were injected with cortisol and L-thyroxine for 5 days and the phosphatidate phosphohydrolase activity was measured on the fifth day 3 h after the last injection (see the Materials and Methods section). There were five rats-in each group. Experiments A and B were carried out on different consignments of rats. The results and the significance between groups are expressed as in Table 2 . , 1972; Roncari & Murthy, 1975) . However, these treatments produce far higher initial concentrations of hormones in the blood than are found physiologically and the results may be related to the pharmacological as well as the physiological effects of these hormones. Roncari & Murthy (1975) reported that treating rats with thyroxine increased the rate of triacylglycerol synthesis from glycerol phosphate in cellfree preparations of the livers. Our (Tables 2 and 3 ). It is likely that this is mediated through an increased activity of diacylglycerol acyltransferase (EC 2.3.1.20) (Young & Lynen, 1969) .
The increased synthesis of triacylglycerols may be partly responsible for the hypertriglyceridaemia that has been reported to occur in hyperthyroid states (Nikkila & Kekki, 1972) . However, there is evidence that the hepatic triacylglycerol is preferentially oxidized within the liver, and that the secretion of very-low-density lipoproteins is decreased (Diamant et al., 1972; Keyes & Heimberg, 1978) . This agrees with the hypotriglyceridaemia that has been observed in thyrotoxic patients (Tulloch et al., 1973) . The degradation of hepatic triacylglycerol is probably catalysed by an acid lipase that is increased in activity after thyroxine treatment (Coates et at., 1978) . This increased turnover of triacylglycerols is a further example of the thermogenic effect of thyroxine, which is mediated through substrate cycling. It is already known that thyroxine stimulates the synthesis and f-oxidation of fatty acids in the liver (Diamant et al., 1972) .
Thyroxine treatment also increases the synthesis of triacylglycerol (Roncari & Murthy, 1975) , the accumulation of triacylglycerol and the rate of fl-oxidation (Bressler & Wittels, 1966) in the myocardium. The hearts of hyperthyroid animals showed an increased synthesis of phosphatidate and an increased activity of the Mg2+-stimulated release of Pi from phosphatidate in the microsomal and lysosomal fractions. However, the activity of the Mg2+-stimulated phosphatidate phosphohydrolase in the soluble fraction was not increased (Kako & Patterson, 1975) .
The administration of corticotropin and cortisol significantly increased the relative proportion of glycerol incorporated into triacylglycerol (Table 3) . This was accompanied by (a) an increase in the relative flux of phosphatidate to diacylglycerol (Tables 2 and 3) (Table 4) . It is therefore likely that the increased phosphohydrolase activity is one of the adaptive changes that predisposes the livers of these rats to synthesize more triacylglycerol. Corticotropin is likely to have produced part of its effect by stimulating the release of cortisol. This release appears to be necessary for producing the fatty liver that is seen after injection of corticotropin (Ozegovic et al., 1975) . Cortisol and other corticosteroids can also produce a fatty liver (Hill & Droke, 1963; Ozegovic et al., 1975) and increase the secretion of very-low-density lipoproteins (Klausner & Heimberg, 1967; Reaven et al., 1974) .
This increased synthesis and secretion of triacylglycerols by the liver may partly result from the increased lipolysis and decreased fatty acid esterification in adipose tissue that can be produced by corticotropin and cortisol (Lebovitz et al., 1965; Scow et al., 1965; Chernick et al., 1972; Litwack & Singer, 1972; Bizzi et al., 1972) . The mobilization of fatty acids together with protein loss from muscle could be responsible for the decreased weight gain observed in the rats treated with corticotropin and cortisol (Table 1) .
High serum concentrations of cortisol are also associated with conditions of excessive fat accumulation such as in Cushing's syndrome and obesity (Rudman & Di Girolamo, 1971; Herberg & Coleman, 1977) . These conditions involve an increased synthesis offatty acids, which are then incorporated into triacylglycerols. Cortisol appears to be involved in this phenomenon, although its effect may be mediated through insulin (Salmon & Hems, 1973; Diamant & Shafrir, 1975; Kirk et al., 1976) . The increased synthesis of triacylglycerols in the livers and adipose tissue of obese (ob/ob) mice is probably facilitated by the increased activity of phosphatidate phosphohydrolase in these organs (Jamdar et al., 1976; Fallon et al., 1977) .
Glucocorticoids appear to play a permissive role in stimulating hepatic triacylglycerol synthesis, and cortisol is known to play an important part in regulating intermediary metabolism in starvation, diabetes and stress conditions. The liver is also responsible for degrading a large portion of the circulatory cortisol, and thus removal is impaired by liver damage (Peterson, 1971 (Ramey & Goldstein, 1957; Rudman & Di Girolamo, 1971) . The activity of phosphatidate phosphohydrolase in the liver is increased in starvation (Vavrecka et al., 1969; Mangiapane et al., 1973) , diabetes (Whiting et al., 1977) , subtotal hepatectomy (Mangiapane et al., 1973) , after the stress ofsurgery (Mangiapane etal., 1973) and as a result of the toxic effects of hydrazine administration (Lamb & Blank, 1977) . There are also marked increases in this activity after ethanol ingestion Savolainen, 1977; . This condition is also accompanied by increased concentrations of circulating glucocorticoids, which may be mediated through an. enhanced corticotropin release or by liver damage (Mendelson, 1971) . The results from the present work establish that cortisol could be directly or indirectly involved in producing these increases in phosphatidate phosphohydrolase activity. An increased specific activity of phosphatidate phosphohydrolase is also seen in fQetal lung during the development of its capacity to synthesize surfactant, but parallel increases in the foetal liver were reported not to have occurred (Johnston et al., 1975) . Glucocorticoids are known to promote the maturation of the lung. Treatment of pregnant rabbits with cortisol increased the activity of the membrane-associated phosphatidate phosphohydrolase in the lungs of the foetuses, but this increase did not reach the level of significance (Possmayer et al., 1977) . Injection of pregnant rabbits with betamethasone does increase the specific activity of the phosphatidate phosphohydrolase in the foetal lungs, but a decreased activity was reported for the foetal livers (Brehier et al., 1977) . The activity of phosphatidate phosphohydrolase in the latter three series of experiments appears to have been measured by the release of P1. This method of assay can overestimate phosphatidate phosphohydrolase activity in particulate fractions of liver. This may have obscured changes in activity that may have been detected had the formation of diacylglycerol been determined .
The present paper demonstrates that injecting rats with corticotropin, cortisol and thyroxine increases the relative rate of hepatic triacylglycerol synthesis. Thyroxine is known to produce a generalized increase in metabolism and it stimulates the synthesis and degradation of fatty acids and triacylglycerols in the liver. Thyroxine did not produce a marked increase in the hepatic activity of phosphatidate phosphohydrolase, but there was evidence that the flux of diacylglycerol to triacylglycerol was increased. Cortisol treatment increased phosphatidate phosphohydrolase activity in the liver by about 2.8-fold, and this increase appears to be associated with a net stimulation of triacylglycerol production.
